|
|
 |
Physician Oriented Information on Testicular Cancer |
This section provides links to professional treatment guidelines, consensus recommendations, statistics, pathology standards, imaging guidance, clinical trials, and expert working groups related to testicular and extragonadal germ cell tumors. The emphasis is on authoritative and substantive resources useful to physicians and other health professionals.
These links are aimed primarily at doctors and medical students. Patients are certainly welcome to use them, but much of the material assumes a medical background. Medical journal articles are listed separately by category on the Medical Articles page. Additional professional material can also be found in the sections on Case Studies, Tumor Markers, Extragonadal Germ Cell Tumors, and Images.
Treatment Guidelines and Consensus Recommendations
- NCCN Clinical Practice Guidelines in Oncology: Testicular Cancer - One of the principal U.S. standards for diagnosis, treatment and follow-up. Registration or login may be required.
- National Cancer Institute Testicular Cancer Information for Health Professionals - NCI's professional testicular cancer resource, including its evidence-based treatment information, screening information, statistics, drugs and clinical trials.
- NCI Professional Testicular Cancer Information in Spanish
- NCI Extragonadal Germ Cell Tumor Information for Health Professionals - Professional information on mediastinal, retroperitoneal and other extragonadal germ cell tumors.
- NCI Extragonadal Germ Cell Tumor Information in Spanish
- American Urological Association Guideline: Diagnosis and Treatment of Early-Stage Testicular Cancer - Evidence-based guidance for diagnosis, staging, treatment selection and surveillance of clinical stages I through IIB seminoma and nonseminoma. The guideline was originally published in 2019 and amended in 2023.
- European Association of Urology Guidelines on Testicular Cancer - Comprehensive guidelines covering diagnosis, staging, treatment, recurrence, follow-up and survivorship. The EAU updates its testicular cancer guideline regularly.
- ESMO Clinical Practice Guideline: Testicular Cancer - European Society for Medical Oncology guidance for diagnosis, treatment and follow-up of seminoma and nonseminoma.
- Canadian Urological Association Consensus Guideline on the Management of Testicular Germ Cell Cancer - Multidisciplinary Canadian consensus recommendations involving urologic oncology, medical oncology, radiation oncology, pathology and radiology.
(In French)
- SWENOTECA Management Programs and Guidelines - Treatment and follow-up protocols from the Swedish and Norwegian Testicular Cancer Group.
- ANZUP Testicular Cancer Recommendations and Resources - Consensus recommendations and professional resources developed by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group, including testicular cancer surveillance recommendations.
- SEOM-GG Clinical Guidelines for the Management of Germ-Cell Testicular Cancer - Open-access clinical guideline from the Spanish Society of Medical Oncology Germ Cell Group, published in 2024.
- French AFU Cancer Committee Guidelines 2024-2026: Testicular Germ Cell Tumors - French recommendations covering diagnosis, pathology, staging, fertility, treatment, relapse and surveillance.
Statistics and Epidemiology
- SEER Cancer Stat Facts: Testicular Cancer - Detailed U.S. statistics including incidence, mortality, survival, prevalence, age distribution, race and ethnicity, lifetime risk and trends.
- IARC Global Cancer Observatory: Testis Cancer Fact Sheet - Worldwide incidence, mortality, prevalence and geographic distribution of testicular cancer.
- Cancer Research UK: Testicular Cancer Statistics - Detailed UK professional statistics on incidence, mortality, survival, risk, diagnosis and treatment.
Pathology Standards and References
Radiology and Imaging
Clinical Trials
Expert Working Groups and Collaborative Groups
Special Professional Resources
- U.S. Navy Aeromedical Reference and Waiver Guide - Current Navy guidance for aeromedical clinicians regarding disqualifying conditions and waiver requirements. Open the complete Aeromedical Reference and Waiver Guide and see Section 9.21, Testicular Tumors for the specific testicular cancer waiver requirements.
|